"Maybe worth even giving the whole distribution away and focus on manufacturing and support." This is exactly the way to go and is straight out of nanosonic's playbook.
AXP should look for a sales and distribution agreement across all of u.s with a major healthcare company. Maybe a 4-5 year deal. Margins will fall but so too will the cost of building up a sales and distribution network and getting market penetration. Hoping it won't need to be exclusive but it is not exactly in a position with the time to bargain.
The strategy they adopted based solely on the early adoption in Oz was misguided and the Dodson paid the price.
AXP Price at posting:
9.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)